How has been the historical performance of ANG Lifesciences?

Answer:The historical performance of ANG Lifesciences shows a significant decline in net sales and profitability over the past few years. Breakdown: ANG Lifesciences experienced a decrease in net sales from INR 354.30 crore in March 2022 to INR 92.85 crore in March 2025. This downward trend is mirrored in total operating income, which fell from INR 354.30 crore in March 2022 to the same INR 92.85 crore in March 2025. The company's operating profit (PBDIT) also declined sharply, moving from a profit of INR 68.28 crore in March 2022 to a loss of INR 0.25 crore in March 2025. Profit before tax followed a similar trajectory, dropping from INR 53.50 crore in March 2022 to a loss of INR 15.70 crore in March 2025. Consequently, profit after tax also turned negative, going from a profit of INR 40.32 crore in March 2022 to a loss of INR 12.41 crore in March 2025. The company's total assets decreased from INR 286.75 crore in March 2022 to INR 223.22 crore in March 2025, while total liabilities also saw a reduction from INR 286.75 crore to INR 223.22 crore in the same period. Cash flow from operating activities has fluctuated, with a notable drop to zero in March 2025, compared to INR 26 crore in March 2023. Overall, ANG Lifesciences has faced significant challenges, reflected in its declining sales, profits, and cash flow over the years.